These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9094256)

  • 1. Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats.
    Bischoff A; Stickan-Verfürth M; Michel MC
    Pflugers Arch; 1997 May; 434(1):57-62. PubMed ID: 9094256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
    Bell D; Millar BC; McDermott BJ
    Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradykinin may be involved in neuropeptide Y-induced diuresis, natriuresis, and calciuresis.
    Bischoff A; Rascher W; Michel MC
    Am J Physiol; 1998 Oct; 275(4):F502-9. PubMed ID: 9755121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
    Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
    Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.
    Bischoff A; Erdbrügger W; Smits J; Michel MC
    J Physiol; 1996 Sep; 495 ( Pt 2)(Pt 2):525-34. PubMed ID: 8887762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat.
    Sun XY; Edvinsson L; Hedner T
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
    Sun XY; Dahlöf C; Edvinsson L; Hedner T
    Eur J Pharmacol; 1991 Nov; 204(3):281-6. PubMed ID: 1773830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor binding.
    Heilig M; Edvinsson L; Wahlestedt C
    Eur J Pharmacol; 1991 Dec; 209(1-2):27-32. PubMed ID: 1667639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic effect of D-myo-inositol-1,2,6-trisphosphate (PP56) on neuropeptide Y-induced vasoconstriction in the feline dental pulp.
    Kim SK; Ang L; Hsu YY; Dörscher-Kim J; Kim S
    Arch Oral Biol; 1996; 41(8-9):791-8. PubMed ID: 9022916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation.
    Pernow J; Modin A; Lundberg JM
    Eur J Pharmacol; 1992 Nov; 222(1):171-4. PubMed ID: 1468494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of pre- and postjunctional responses to neuropeptide Y and sympathetic stimulation by D-myo-inositol-1,2,6-trisphosphate in the anaesthetised dog.
    Potter EK; Edvinsson L; Gustafsson T
    Eur J Pharmacol; 1992 Oct; 221(2-3):307-14. PubMed ID: 1426007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin inhibits the natriuretic effects of neuropeptide Y in anesthetized rats.
    Bischoff A; Limmroth V; Michel MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):704-8. PubMed ID: 9694924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
    Schwieler JH; Hjemdahl P
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-myo inositol 1,2,6, triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling?
    Bell D; McDermott BJ
    Gen Pharmacol; 1998 Nov; 31(5):689-96. PubMed ID: 9809464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission.
    Sun XY; Edvinsson L; Yoo H; Wahlestedt C; Hedner T
    J Cardiovasc Pharmacol; 1995 May; 25(5):696-704. PubMed ID: 7630147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of D-myo-inositol-1,2,6-trisphosphate on glucose-stimulated insulin secretion in the mouse.
    Ahrén B
    Neuropeptides; 1992 Mar; 21(3):163-6. PubMed ID: 1630602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y-induced pressor responses in spontaneously hypertensive and Wistar-Kyoto rats antagonized by D-myo-inositol-1,2,6-triphosphate (PP56).
    Sun XY; Edvinsson L; Hedner T
    J Hypertens Suppl; 1991 Dec; 9(6):S344-5. PubMed ID: 1818993
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular and renal effects of alpha-trinositol in ischemic heart failure rats.
    Sun XY; Feng QP; Zhao X; Edvinsson L; Hedner T
    Life Sci; 1995; 57(12):1197-211. PubMed ID: 7674809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is PP56 (D-myo-inositol-1,2,6-trisphosphate) an antagonist at neuropeptide Y receptors?
    Feth F; Erdbrügger W; Rascher W; Michel MC
    Life Sci; 1993; 52(23):1835-44. PubMed ID: 8388981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteries.
    Edvinsson L; Adamsson M; Jansen I
    Neuropeptides; 1990 Oct; 17(2):99-105. PubMed ID: 2280824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.